MARKSANS PHARMA LTD. - 524404 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on 11th August, 202111-08-2021
11-08-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached an investors presentation of Marksans Pharma Limited for Q1 FY22.11-08-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 11th August, 2021 of the Company.11-08-2021
MARKSANS PHARMA LTD. - 524404 - Unaudited Financial Results For The Quarter Ended 30Th June, 2021 And Limited Review Reports Thereon.
In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th June, 2021 approved by the Board of Directors at its meeting held today i.e. 11th August, 2021 along with Limited Review Reports given by statutory auditor of the Company. The meeting commenced at 11:00 a.m. and concluded at 12:10 p.m.11-08-2021
Marksans Pharma Ltd - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201504-08-2021
Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Notice Of Board Meeting
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended 30th June, 2021. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company''s shares has been closed for the Company''s insiders from 1st July, 2021 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on 11th August, 2021.28-07-2021
MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201527-07-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, enclosed herewith kindly find reporting of violations related to Code of Conduct under SEBI (PIT) Regulations, 2015 by two Designated Persons of the Company in the prescribed formats.24-07-2021
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, enclosed herewith kindly find reporting of violations related to Code of Conduct under SEBI (PIT) Regulations, 2015 by two Designated Persons of the Company in the prescribed formats.24-07-2021